Metavention is leveraging unique insights into the role of the sympathetic nervous system in diabetes to develop Metabolic Neuromodulation Therapy (MNT). MNT is a minimally invasive cardiovascular procedure that involves passing a catheter into the arteries surrounding the liver and delivering energy to disrupt nearby nerves, resulting in restoring the liver to a more normal state of glucose processing and aid in the control of hyperglycemia. Metavention seeks to develop a safe and effective treatment that can aid patients with type 2 diabetes who are struggling to control their blood sugar with lifestyle modification and non-insulin antidiabetic agents.